MediWound (MDWD) to Release Earnings on Wednesday

MediWound (NASDAQ:MDWD) is anticipated to announce its earnings results before the market opens on Wednesday, March 19th. Analysts expect the company to announce earnings of ($0.61) per share and revenue of $5.79 million for the quarter. Parties that wish to register for the company’s conference call can do so using this link.

MediWound Stock Performance

MDWD opened at $19.09 on Tuesday. The company has a 50-day moving average of $18.07 and a 200-day moving average of $17.59. The company has a market capitalization of $205.90 million, a P/E ratio of -6.58 and a beta of 0.82. MediWound has a 1-year low of $12.78 and a 1-year high of $24.00.

Analyst Upgrades and Downgrades

MDWD has been the subject of several research analyst reports. HC Wainwright reissued a “buy” rating and issued a $25.00 target price on shares of MediWound in a research report on Friday, January 10th. Craig Hallum initiated coverage on shares of MediWound in a research report on Friday, February 28th. They issued a “buy” rating and a $39.00 target price for the company.

About MediWound

MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in United States, Europe, and internationally. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units.